Actinium Pharmaceuticals (ATNM) Q4 2025 Earnings

14NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.51
-0.39
-0.28
-0.16

Details

Expected EPS
-0.18
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+11.11%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.16 per share for Q4 2025.

0 Comments

Share your thoughts